Brooke A Dancho

Title: Brooke A. Dancho: Innovator in Monoclonal Antibody Research

Introduction

Brooke A. Dancho is a notable inventor based in Athens, GA (US), recognized for her contributions to the field of immunology. She has developed significant innovations, particularly in the area of monoclonal antibodies targeting the foot-and-mouth disease virus (FMDV). Her work has implications for both veterinary medicine and agricultural biosecurity.

Latest Patents

Dancho holds a patent for a monoclonal antibody against novel epitopes of the foot-and-mouth disease virus protein 3ABC. This patent includes isolated antibodies or antigen-binding fragments that specifically bind to the 3ABC non-structural protein of FMDV. The antibodies recognize specific amino acid sequences, which are crucial for detecting FMDV infections in animals. The patent also covers methods for differentiating infected animals from vaccinated ones, along with the development of competitive ELISA kits for effective detection.

Career Highlights

Throughout her career, Dancho has worked with esteemed institutions, including the Texas A&M University System and the United States Department of Agriculture. Her research has significantly advanced the understanding of FMDV and has contributed to the development of diagnostic tools that enhance animal health management.

Collaborations

Dancho has collaborated with notable colleagues such as Alfonso Clavijo and Aida Elizabeth Rieder. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of knowledge in the field of immunology.

Conclusion

Brooke A. Dancho's work exemplifies the impact of innovative research in the field of veterinary medicine. Her contributions to monoclonal antibody development are vital for improving disease detection and management in livestock.